Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
META Pharmaceuticals Logo
META Pharmaceuticals Growth Score
90
CB Rank
42500
Heat Score
40
META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases.
Founded
obfuscation
PrivateVenture - Series Unknown Shenzhen, Guangdong, China1-10 en.metabiopharma.com/
Medical
Pharmaceutical
Overview

META Pharmaceuticals
Total Funding
obfuscation
Growth Score
90
Heat Score
40

Total Funding
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score90
-3 pts
in past quarter
Heat Score 40
7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About META Pharmaceuticals

CB Rank
42500
META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases.
Founded
obfuscation
PrivateVenture - Series Unknown Shenzhen, Guangdong, China1-10 en.metabiopharma.com/
Medical
Pharmaceutical

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Details

Legal Name META Pharmaceuticals Inc.
Also Known As Moda Biotech, Moda Bio
Operating Status Active
Company Type For Profit
About the Company
META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

META-001-PH
A small molecule drug candidate designed to treat Primary Hyperoxaluria by inhibiting oxalate synthesis, reducing urinary oxalate levels.
META-1
A first-in-class small molecule inhibitor targeting immune metabolism pathways for treating autoimmune diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - META Pharmaceuticals Logo
Venture Round - META Pharmaceuticals
3
obfuscation
XtalPiVenture - Series Unknown
obfuscation
Venture Round - META Pharmaceuticals Logo
Venture Round - META Pharmaceuticals
3
obfuscation
XtalPiVenture - Series Unknown
obfuscation
Venture Round - META Pharmaceuticals Logo
Venture Round - META Pharmaceuticals
3
obfuscation
XtalPiVenture - Series Unknown
obfuscation
Venture Round - META Pharmaceuticals Logo
Venture Round - META Pharmaceuticals
3
obfuscation
XtalPiVenture - Series Unknown
obfuscation
Venture Round - META Pharmaceuticals Logo
Venture Round - META Pharmaceuticals
3
obfuscation
XtalPiVenture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - META Pharmaceuticals Logo
Venture Round - META Pharmaceuticals
3
obfuscation
XtalPiVenture - Series Unknown
obfuscation
Venture Round - META Pharmaceuticals Logo
Venture Round - META Pharmaceuticals
3
obfuscation
XtalPiVenture - Series Unknown
obfuscation
Venture Round - META Pharmaceuticals Logo
Venture Round - META Pharmaceuticals
3
obfuscation
XtalPiVenture - Series Unknown
obfuscation
Venture Round - META Pharmaceuticals Logo
Venture Round - META Pharmaceuticals
3
obfuscation
XtalPiVenture - Series Unknown
obfuscation
Venture Round - META Pharmaceuticals Logo
Venture Round - META Pharmaceuticals
3
obfuscation
XtalPiVenture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 18, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 14, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

8META Pharmaceuticals is actively using 8 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Common Crawl, and  Viewport Meta.
Sub-Organizations
Frequently Asked Questions

Where is META Pharmaceuticals's headquarters? META Pharmaceuticals is located in Shenzhen, Guangdong, China.Who invested in META Pharmaceuticals? META Pharmaceuticals has 8 investors including XtalPi and  IMO Ventures.When was the last funding round for META Pharmaceuticals? META Pharmaceuticals closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are META Pharmaceuticals's competitors? Alternatives and possible competitors to META Pharmaceuticals may include Q32 Bio, Accro Bioscience, and  Roivant Sciences.How much funding has META Pharmaceuticals raised to date? META Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3ff49e4 1)
|